16S rRNA mutations for improved Sec insertion efficiency at the ribosome |
Luciferase reporter downstream of SECIS element, endogenous FDH |
Luciferase activity of reporter, benzyl viologen assay, for endogenous FDH activities |
Best mutants, ≈30% |
Unclear, not quantified |
UGA truncation, Trp-mediated UGA suppression |
Thyer et al. (31) |
Synthetic tRNAUtu species for EF-Tu-mediated Sec insertion at either UGA or UAG codons |
Endogenous FDH, GPx1 or Sec-substituted Grx1 |
Benzyl viologen assay for endogenous FDH, mass spectrometry of Grx1, enzyme activities of Grx1 and GPx1 |
≈50–65% (Sec-Grx1 vs. Ser-Grx1 or Sec-GPx1 vs. Ser-GPx1), double activity of Sec-Grx1 vs. Cys-Grx1, GPx1 ≈6 units/mg |
Unclear, not quantified |
Ser-mediated suppression |
Aldag et al. (28) |
SelB-mediated suppression of alternative codons using tRNASec variants with altered anticodon sequences |
Endogenous FDH, human TrxR1 |
Benzyl viologen assay for endogenous activities of FDH and specific activities of purified FDH, mass spectrometry, specific activity of TrxR |
FDH, 12–100% depending upon codon usage; TrxR ≈95–98% |
FDH, up to 12-fold levels of endogenous wild type FDH; TrxR unclear, not quantified |
Unclear, codon-dependent |
Bröcker et al. (29) |
Engineered tRNASec for EF-Tu-mediated Sec insertion at UAG, also tested in the RF1- depleted C321.ΔA host |
Sec-substituted NMC-A β-lactamase, endogenous FDH, Sec-substituted DHFR, Sec-substituted azurin, human GPx1 |
Antibiotic resistance due to functional β-lactamase, benzyl viologen assay for endogenous FDH, mass spectrometry |
Sec-DHFR, ≈100%, other selenoproteins produced unclear specificity |
Unclear, not quantified |
Ser-mediated suppression |
Thyer et al. (32) |
Further engineered tRNASec for EF-Tu-mediated Sec insertion at UAG with lower Ser-mediated suppression |
Endogenous FDH, Sec-substituted Grx1 |
Benzyl viologen assay for endogenous FDH, specific activities of FDG and Sec-substituted Grx1, mass spectrometry |
FDH, ≈70%; Grx1, ≈100% |
Unclear, not quantified using expression in vivo; in cell-free systems ≈2–80 ng obtained per reaction depending upon construct |
Ser-mediated suppression |
Miller et al. (30) |
UAG-directed Sec insertion in RF1-depleted host, with or without bacterial SECIS element |
Rat and human TrxR isoenzymes, human GPx1 |
Enzyme activities and mass spectrometry |
With SECIS, ≥95%. No SECIS, ≈30%. TrxR1 ≈35–40 units/mg. GPx1 ≈10 units/mg |
With SECIS, ≈20 mg/liter. No SECIS, 1–3 mg/liter |
UAG-directed truncation, Gln- and Lys-mediated suppression |
This work |